Cris Loiren Rodriguez

Array ( [id] => 8683875 [patent_doc_number] => 20130052159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'METHODS FOR TREATMENT OF MICROBIAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/566760 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 43859 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974183 [patent_doc_number] => 20140377218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'HCV IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/236079 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8203 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11184777 [patent_doc_number] => 09416168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'IL-17R-ECD mutants and methods of using same' [patent_app_type] => utility [patent_app_number] => 14/232921 [patent_app_country] => US [patent_app_date] => 2012-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15054 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909227 [patent_doc_number] => 08481288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Polynucleotides encoding antibodies that bind both IL-17A and IL-17F' [patent_app_type] => utility [patent_app_number] => 13/539534 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909227 [patent_doc_number] => 08481288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Polynucleotides encoding antibodies that bind both IL-17A and IL-17F' [patent_app_type] => utility [patent_app_number] => 13/539534 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909227 [patent_doc_number] => 08481288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Polynucleotides encoding antibodies that bind both IL-17A and IL-17F' [patent_app_type] => utility [patent_app_number] => 13/539534 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909227 [patent_doc_number] => 08481288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Polynucleotides encoding antibodies that bind both IL-17A and IL-17F' [patent_app_type] => utility [patent_app_number] => 13/539534 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943760 [patent_doc_number] => 08496936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Antagonists of IL-17A, IL-17F, and IL-23P19' [patent_app_type] => utility [patent_app_number] => 13/534019 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50409 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452783 [patent_doc_number] => 20120263729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 13/533727 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 40898 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495903 [patent_doc_number] => 20120295310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'NUCLEIC ACIDS ENCODING ANTI-IL-23 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/528918 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74942 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431141 [patent_doc_number] => 20120253016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'ANTIBODY MOLECULES THAT BIND TO IL-6 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/524528 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22208 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581697 [patent_doc_number] => 08771697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies' [patent_app_type] => utility [patent_app_number] => 13/492280 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34342 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13492280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9908992 [patent_doc_number] => 20150064193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'METHODS OF TREATING PSORIATIC ARTHRITIS (PSA) USING IL-17 ANTAGONISTS AND PSA RESPONSE OR NON-RESPONSE ALLELES' [patent_app_type] => utility [patent_app_number] => 14/358504 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31485 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330184 [patent_doc_number] => 20140056966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE CONJUGATE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/488932 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10423 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490277 [patent_doc_number] => 20120289684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/487828 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 79362 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629399 [patent_doc_number] => 08361470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Methods of treatment using anti-human IL-21 monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 13/474001 [patent_app_country] => US [patent_app_date] => 2012-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 46442 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874701 [patent_doc_number] => 08961965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Methods of diagnosing and treating pulmonary diseases or disorders' [patent_app_type] => utility [patent_app_number] => 13/474459 [patent_app_country] => US [patent_app_date] => 2012-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 34527 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12565983 [patent_doc_number] => 10017568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same [patent_app_type] => utility [patent_app_number] => 14/115549 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 18 [patent_no_of_words] => 115037 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441851 [patent_doc_number] => 20120258468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'INDICATOR AGENT FOR NONINFLAMMATORY STRESS RESPONSE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/452048 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18141 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408984 [patent_doc_number] => 09556276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Anti-human IL-23 receptor antibody' [patent_app_type] => utility [patent_app_number] => 14/007030 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13095 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007030 [rel_patent_id] =>[rel_patent_doc_number] =>)